Pictor Holdings Raises $7.5 Million to Scale Proteomic Platform

The financing, backed by existing investors, arrives as the company builds on a year of steady growth. Since establishing its U.S. headquarters, Pictor has brought seven commercial products to market and finalized four strategic partnerships. The leadership team also expanded recently with the appointments of Terry Kelly as Chief Operating Officer and Tim Shannon as Chief Financial Officer.

At the core of the company’s offering is a platform featuring the PictArray and PictImager systems, alongside Pictorial software. This technology allows laboratories to process up to 20 protein targets from one sample in less than two hours, a workflow designed to lower costs for reference labs and pharmaceutical firms. CEO Jamie Platt noted that the goal is to make protein insights more accessible beyond specialized, large-scale settings, effectively reducing the consumption of resources per test.

Looking ahead, the company is preparing for a potential Series A financing round to further scale operations. Executives expect to move into formal licensing stages with multiple partners within the coming 12 to 18 months. According to CFO Tim Shannon, this bridge capital provides the necessary runway to solidify the company's commercial position before that larger milestone.